24 related articles for article (PubMed ID: 38555208)
1. Survival outcomes and establishment of a novel risk stratification system in patients with ovarian yolk sac tumors.
Li S; Zhang X; Zhang T; Zhang R; Cao D; Xiang Y; Yang J
Gynecol Oncol; 2023 Nov; 178():145-152. PubMed ID: 37865050
[TBL] [Abstract][Full Text] [Related]
2. Treatment of malignant ovarian germ cell tumors and preservation of fertility.
Zhang R; Sun YC; Zhang GY; Wu LY; Zuo J
Eur J Gynaecol Oncol; 2012; 33(5):489-92. PubMed ID: 23185794
[TBL] [Abstract][Full Text] [Related]
3. Surveillance Only for High-risk FIGO Stage IA/IB Malignant Ovarian Germ Cell Tumors: Results From a National Cancer Database.
Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb KM
Am J Clin Oncol; 2021 May; 44(5):195-199. PubMed ID: 33710136
[TBL] [Abstract][Full Text] [Related]
4. Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network.
Derquin F; Floquet A; Hardy-Bessard AC; Edeline J; Lotz JP; Alexandre J; Pautier P; Angeles MA; Delanoy N; Lefeuvre-Plesse C; Cancel M; Treilleux I; Augereau P; Lavoue V; Kalbacher E; Berton Rigaud D; Selle F; Nadeau C; Gantzer J; Joly F; Guillemet C; Pomel C; Favier L; Abdeddaim C; Venat-Bouvet L; Provansal M; Fabbro M; Kaminsky MC; Lortholary A; Lecuru F; Coquard IR; de La Motte Rouge T
Gynecol Oncol; 2020 Sep; 158(3):666-672. PubMed ID: 32624235
[TBL] [Abstract][Full Text] [Related]
5. Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study.
Mangili G; Sigismondi C; Gadducci A; Cormio G; Scollo P; Tateo S; Ferrandina G; Greggi S; Candiani M; Lorusso D
Int J Gynecol Cancer; 2011 Nov; 21(8):1414-21. PubMed ID: 21795985
[TBL] [Abstract][Full Text] [Related]
6. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
7. [Malignant ovarian germ cell tumors. Current status of diagnosis and treatment].
Torres-Lobatón A
Ginecol Obstet Mex; 2014 Mar; 82(3):177-87. PubMed ID: 24779273
[TBL] [Abstract][Full Text] [Related]
8. Mixed mesodermal tumors of the ovary: a clinicopathologic study of 14 cases.
Dinh TV; Slavin RE; Bhagavan BS; Hannigan EV; Tiamson EM; Yandell RB
Obstet Gynecol; 1988 Sep; 72(3 Pt 1):409-12. PubMed ID: 2841630
[TBL] [Abstract][Full Text] [Related]
9. Conundrums in the management of malignant ovarian germ cell tumors: Toward lessening acute morbidity and late effects of treatment.
Gershenson DM; Frazier AL
Gynecol Oncol; 2016 Nov; 143(2):428-432. PubMed ID: 27569583
[TBL] [Abstract][Full Text] [Related]
10. Ovarian malignant germ cell tumors: cellular classification and clinical and imaging features.
Shaaban AM; Rezvani M; Elsayes KM; Baskin H; Mourad A; Foster BR; Jarboe EA; Menias CO
Radiographics; 2014; 34(3):777-801. PubMed ID: 24819795
[TBL] [Abstract][Full Text] [Related]
11. Component Patterns and Survival Outcomes in Patients with Mixed Malignant Ovarian Germ Cell Tumors: A Retrospective Cohort Study.
Li S; Zhang R; Zhang X; Zhang T; Cao D; Xiang Y; Yang J
Clin Oncol (R Coll Radiol); 2024 Jun; 36(6):370-377. PubMed ID: 38555208
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]